Nabeel Shakir, MD
Urology · Detroit, MINPI 1033505896
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by KARL Storz Endoscopy-america at 52.5% of the total. Reporting peaked in 2023 at $1,470 and has fallen 86.6% since, to $198 in 2025. That places this record below the midpoint for urology clinicians in MI, where the typical reported total is $2,586.
Across 21 payments — averaging $133.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KARL Storz Endoscopy-america$1K
- Boston Scientific$304
- EDAP Technomed Inc$291
- Coloplast$287
- Medtronic$132
- Intuitive Surgical$110
- plus $208 from 3 others
What the payments were for
- Speaking & faculty fees$1,47052%
- Food & beverage$1,33248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KARL Storz Endoscopy-america | 1 | $1,470 |
| Boston Scientific | 5 | $304 |
| EDAP Technomed Inc | 3 | $291 |
| Coloplast | 5 | $287 |
| Medtronic(2 entities) | 2 | $132 |
| Intuitive Surgical | 1 | $110 |
| Ambu Inc. | 2 | $104 |
| Procept Biorobotics Corporation | 1 | $90 |
| Urogen Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$244
- GENERAL MALE SUI$113
- Da Vinci Surgical System$110
How this compares
$2,802 in reported general payments places this provider in the 50th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 21 | $10,787 |
| Tamsulosin Hcl | 88 | $1,344 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $904 |
| Finasteride | 32 | $499 |
| Methenamine Hippurate | 11 | $434 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $190 |
| Oxybutynin Chloride | 17 | $115 |
| Triamcinolone Acetonide | 13 | $80 |
| CefuroximeCefuroxime Axetil | 17 | $70 |
| Levofloxacin | 22 | $52 |
Paid to pharmacies, not to this prescriber.
Other urology in Detroit
- Aram LoebDetroit$112K
- David LeavittDetroit$59K
- Craig RogersDetroit$25K
- Naveen KachrooDetroit$25K
- Amit PatelDetroit$22K
- Asha JamzadehDetroit$21K
- Firas AbdollahDetroit$20K
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.